Windsor Machines Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 10:40 pm

Competitors of Windsor Machines Ltd

All Competitor Stocks of Windsor Machines Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:10 am

Below is a detailed analysis of the quarterly data for Windsor Machines Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 113.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Mar 2025) to 113.00 Cr., marking a decrease of 8.00 Cr..
• For Expenses, as of Jun 2025, the value is 105.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 110.00 Cr. (Mar 2025) to 105.00 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 7.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is -12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Mar 2025) to -12.00 Cr., marking a decrease of 12.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to -9.00 Cr., marking a decrease of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is 13.00%. The value appears to be improving (decreasing) as expected. It has decreased from 193.00% (Mar 2025) to 13.00%, marking a decrease of 180.00%.
• For Net Profit, as of Jun 2025, the value is -11.00 Cr.. The value appears to be declining and may need further review. It has decreased from -4.00 Cr. (Mar 2025) to -11.00 Cr., marking a decrease of 7.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.25. The value appears to be declining and may need further review. It has decreased from -0.49 (Mar 2025) to -1.25, marking a decrease of 0.76.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:24 pm

Growth

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: September 10, 2025, 2:50 pm

Below is a detailed analysis of the balance sheet data for Windsor Machines Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 717.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2024) to 717.00 Cr., marking an increase of 463.00 Cr..
• For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 36.00 Cr. (Mar 2024) to 35.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing). It has decreased from 291.00 Cr. (Mar 2024) to 233.00 Cr., marking a decrease of 58.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,002.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 593.00 Cr. (Mar 2024) to 1,002.00 Cr., marking an increase of 409.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 323.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 329.00 Cr..
• For CWIP, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 330.00 Cr.. The value appears strong and on an upward trend. It has increased from 251.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 79.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,002.00 Cr.. The value appears strong and on an upward trend. It has increased from 593.00 Cr. (Mar 2024) to 1,002.00 Cr., marking an increase of 409.00 Cr..

Notably, the Reserves (717.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Windsor Machines Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.47. This value is below the healthy minimum of 5. It has increased from -1.19 (Mar 24) to -0.47, marking an increase of 0.72.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has increased from -1.19 (Mar 24) to -0.44, marking an increase of 0.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.74. This value is below the healthy minimum of 3. It has increased from 1.22 (Mar 24) to 1.74, marking an increase of 0.52.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.90. It has increased from 42.76 (Mar 24) to 86.90, marking an increase of 44.14.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.90. It has increased from 42.76 (Mar 24) to 86.90, marking an increase of 44.14.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 43.65. It has decreased from 54.51 (Mar 24) to 43.65, marking a decrease of 10.86.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 3.89 (Mar 24) to 3.02, marking a decrease of 0.87.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.89. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 0.89, marking a decrease of 0.59.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.36. This value is within the healthy range. It has increased from -0.86 (Mar 24) to 2.36, marking an increase of 3.22.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 2. It has increased from -1.19 (Mar 24) to -0.38, marking an increase of 0.81.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 2. It has increased from -1.19 (Mar 24) to 0.87, marking an increase of 2.06.
• For PBDIT Margin (%), as of Mar 25, the value is 6.92. This value is below the healthy minimum of 10. It has decreased from 7.13 (Mar 24) to 6.92, marking a decrease of 0.21.
• For PBIT Margin (%), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 10. It has decreased from 2.71 (Mar 24) to 2.05, marking a decrease of 0.66.
• For PBT Margin (%), as of Mar 25, the value is 5.40. This value is below the healthy minimum of 10. It has increased from -1.58 (Mar 24) to 5.40, marking an increase of 6.98.
• For Net Profit Margin (%), as of Mar 25, the value is -0.87. This value is below the healthy minimum of 5. It has increased from -2.17 (Mar 24) to -0.87, marking an increase of 1.30.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 8. It has increased from -2.17 (Mar 24) to 2.01, marking an increase of 4.18.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 15. It has increased from -2.88 (Mar 24) to 1.01, marking an increase of 3.89.
• For Return on Capital Employeed (%), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 10. It has decreased from 2.39 (Mar 24) to 0.92, marking a decrease of 1.47.
• For Return On Assets (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from -1.29 (Mar 24) to 0.74, marking an increase of 2.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.01, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.13 (Mar 24) to 0.01, marking a decrease of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.46. It has decreased from 0.60 (Mar 24) to 0.46, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has increased from 0.78 (Mar 24) to 1.78, marking an increase of 1.00.
• For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.98, marking an increase of 0.77.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.87. This value is below the healthy minimum of 4. It has decreased from 2.59 (Mar 24) to 1.87, marking a decrease of 0.72.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -84.35 (Mar 24) to 0.00, marking an increase of 84.35.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 81.74 (Mar 24) to 0.00, marking a decrease of 81.74.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 184.35 (Mar 24) to 0.00, marking a decrease of 184.35.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 18.26 (Mar 24) to 0.00, marking a decrease of 18.26.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.18. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 3.18, marking an increase of 1.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 3. It has decreased from 0.49 (Mar 24) to -1.94, marking a decrease of 2.43.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,629.70. It has increased from 472.52 (Mar 24) to 2,629.70, marking an increase of 2,157.18.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.13. This value exceeds the healthy maximum of 3. It has increased from 1.33 (Mar 24) to 7.13, marking an increase of 5.80.
• For EV / EBITDA (X), as of Mar 25, the value is 102.99. This value exceeds the healthy maximum of 15. It has increased from 18.72 (Mar 24) to 102.99, marking an increase of 84.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.36. This value exceeds the healthy maximum of 3. It has increased from 1.21 (Mar 24) to 7.36, marking an increase of 6.15.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 184.35 (Mar 24) to 0.00, marking a decrease of 184.35.
• For Price / BV (X), as of Mar 25, the value is 3.70. This value exceeds the healthy maximum of 3. It has increased from 1.61 (Mar 24) to 3.70, marking an increase of 2.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.36. This value exceeds the healthy maximum of 3. It has increased from 1.21 (Mar 24) to 7.36, marking an increase of 6.15.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.00, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness